Amgen Inc. (SNSE:AMGN)

Amgen Statistics

Total Valuation

Amgen has a market cap or net worth of CLP 174.50 trillion. The enterprise value is 214.65 trillion.

Market Cap	174.50T
Enterprise Value	214.65T

Important Dates

The next estimated earnings date is Thursday, April 30, 2026.

Earnings Date	Apr 30, 2026
Ex-Dividend Date	Feb 13, 2026

Share Statistics

Current Share Class	539.07M
Shares Outstanding	n/a
Shares Change (YoY)	+0.19%
Shares Change (QoQ)	+0.18%
Owned by Insiders (%)	0.15%
Owned by Institutions (%)	81.27%
Float	537.71M

Valuation Ratios

The trailing PE ratio is 25.12 and the forward PE ratio is 16.64.

PE Ratio	25.12
Forward PE	16.64
PS Ratio	5.27
PB Ratio	22.37
P/TBV Ratio	n/a
P/FCF Ratio	23.92
P/OCF Ratio	19.45
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.67, with an EV/FCF ratio of 29.42.

EV / Earnings	30.90
EV / Sales	6.74
EV / EBITDA	14.67
EV / EBIT	21.39
EV / FCF	29.42

Financial Position

The company has a current ratio of 1.14, with a Debt / Equity ratio of 6.40.

Current Ratio	1.14
Quick Ratio	0.73
Debt / Equity	6.40
Debt / EBITDA	3.29
Debt / FCF	6.84
Interest Coverage	3.66

Financial Efficiency

Return on equity (ROE) is 106.10% and return on invested capital (ROIC) is 18.77%.

Return on Equity (ROE)	106.10%
Return on Assets (ROA)	7.93%
Return on Invested Capital (ROIC)	18.77%
Return on Capital Employed (ROCE)	17.78%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	1.05B
Profits Per Employee	220.50M
Employee Count	28,000
Asset Turnover	0.40
Inventory Turnover	1.62

Taxes

In the past 12 months, Amgen has paid 1.14 trillion in taxes.

Income Tax	1.14T
Effective Tax Rate	14.09%

Stock Price Statistics

The stock price has increased by +30.42% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+30.42%
50-Day Moving Average	314.15
200-Day Moving Average	269.91
Relative Strength Index (RSI)	100.00
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.56

Income Statement

In the last 12 months, Amgen had revenue of CLP 33.10 trillion and earned 6.95 trillion in profits. Earnings per share was 12,817.96.

Revenue	33.10T
Gross Profit	23.43T
Operating Income	10.43T
Pretax Income	8.09T
Net Income	6.95T
EBITDA	14.97T
EBIT	10.43T
Earnings Per Share (EPS)	12,817.96

Balance Sheet

The company has 8.22 trillion in cash and 49.93 trillion in debt, with a net cash position of -41,711.06 billion.

Cash & Cash Equivalents	8.22T
Total Debt	49.93T
Net Cash	-41,711.06B
Net Cash Per Share	n/a
Equity (Book Value)	7.80T
Book Value Per Share	14,474.51
Working Capital	3.21T

Cash Flow

In the last 12 months, operating cash flow was 8.97 trillion and capital expenditures -1,673.63 billion, giving a free cash flow of 7.30 trillion.

Operating Cash Flow	8.97T
Capital Expenditures	-1,673.63B
Free Cash Flow	7.30T
FCF Per Share	n/a

Margins

Gross margin is 70.78%, with operating and profit margins of 31.49% and 20.98%.

Gross Margin	70.78%
Operating Margin	31.49%
Pretax Margin	24.42%
Profit Margin	20.98%
EBITDA Margin	45.22%
EBIT Margin	31.49%
FCF Margin	22.04%

Dividends & Yields

This stock pays an annual dividend of 8,965.01, which amounts to a dividend yield of 2,693.97%.

Dividend Per Share	8,965.01
Dividend Yield	2,693.97%
Dividend Growth (YoY)	4.80%
Years of Dividend Growth	13
Payout Ratio	66.45%
Buyback Yield	-0.19%
Shareholder Yield	2,693.79%
Earnings Yield	3.98%
FCF Yield	4.18%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Amgen has an Altman Z-Score of 1.65 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.65
Piotroski F-Score	7